Compared to AMC, both COVID-19 and CAP patients showed elevated levels of IL-6 (COVID-19 p = 0.0296, CAP p = 0.0106, Figure 5A), VEGF (COVID-19 p < 0.0001, CAP p = 0.0032, Figure 5B), and sTNFRI (COVID-19 p < 0.0001, CAP p < 0.0001, Figure 5C). The gene discussed is IL6; the disease is COVID-19.